Browse the full record of transactions filed by member/Executive/Associated Person Maziar Mike Doustdar, Executive. Director active across 1 company, notably Novo Nordisk A/S. Cumulatively, 1 reports have been recorded. Activity tracked since 12 February 2019. The latest transaction was disclosed on 12 February 2019 (Sale). Regulator: Finanstilsynet DK. The full history is free.
1 of 1 declaration
Maziar Mike Doustdar is an associated member of Novo Nordisk A/S. He contributes to the leadership of the company, which is a global leader in healthcare, particularly in diabetes treatment. Novo Nordisk A/S is recognized for its commitment to innovation and improving patient care. Maziar Mike Doustdar plays a key role in implementing the company's strategy.